Three days of scientific exchange, workshops, and new impulses: Until July 2, 2025, members of the Bonn-Cumming Host-Directed Pandemic Therapeutics Program are gathered at University Hospital Bonn (UKB) for a symposium to reflect on the current state of their research and discuss further steps. The joint program of the Cumming Global Centre for Pandemic Therapeutics at the University of Melbourne and of the University of Bonn aims to combat future pandemics with novel therapeutics.

For a two day visit, the Faculty of Medicine at the University of Bonn welcomed 14 medical students accompanied by the deputy director of the teaching office of the Shanghai East International Medical Centre and a research associate from Tongji University in Shanghai. During a varied program, the guests from China were given an insight into studies and research at the Faculty of Medicine Bonn. The aim of the visit was to discuss specialist topics and future exchange opportunities.

The 2025 ENTRANCE Regional Conference, held February 20-21 at the University of Bonn, attracted a host of experts from various universities and research organizations. The main topics were Chinese research, IT and data security, and medical research cooperation.

The Faculty of Medicine at the University of Bonn has conferred an honorary doctorate on the illustrious researcher Professor Sharon Lewin. The Director of the Peter Doherty Institute for Infection and Immunity and the Cumming Global Centre for Pandemic Therapeutics, Professor Lewin is also a Laureate Professor of Medicine at the University of Melbourne in Australia and collaborates with the University Hospital Bonn. She is being recognized for her exceptional research on the international stage and her groundbreaking work in the field of HIV research in particular.

An unprecedented program is to be rolled out to deal with future pandemics: Researchers from the Universities of Melbourne and Bonn and University Hospital of Bonn are teaming up with a billionaire backer to develop new therapeutics and strengthen natural immune response. The Cumming Global Centre and the University of Bonn have today announced the creation of the Bonn-Cumming Host-Directed Pandemic Therapeutics Research Program. Initial program funding of €6 million may potentially be increased to up to €40 million. Philanthropic billionaire Geoff Cumming is putting up a large part of this funding.